Cullinan Therapeutics, Inc. CGEM Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermInvestments.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s equity method investments?
- Cullinan Therapeutics, Inc. (CGEM) reported equity method investments of $38.5M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s equity method investments changed year-over-year?
- Cullinan Therapeutics, Inc.'s equity method investments decreased by 85.2% year-over-year, from $259.39M to $38.5M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.